February 11, 2022 PAO-02-22-R250-12
As a stop on Pharma's Almanac's Road to 50 States road trip, Mike Fiske, Vice President of Manufacturing Sciences at Scorpion Biological Services, talks to Nigel about the company's unique position as an end-to-end provider in the CDMO space and how automation will enhance Scorpion's analytical service offerings.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
Scorpion Biological Services (Scorpion) is a contract research, and contract development and manufacturing organization (CDMO) focused on cell- and gene-based therapies and large molecule biologics. Scorpion provides a broad portfolio of R&D, analytical and biomanufacturing services that enable academic laboratories, research institutes, as well as pharmaceutical and biotech companies to advance their discoveries and deliver new therapies to patients.